Post Market Registry Study of Intracranial Aneurysms Treated With Sugita Clipping Devices
NCT ID: NCT06798740
Last Updated: 2025-01-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
150 participants
OBSERVATIONAL
2025-02-15
2033-02-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Airway Management With Supraglottic Devices in Unruptured Intracranial Aneurysms
NCT03632902
Aneurysm Embolization System for Intracranial Aneurysms
NCT06485492
TARGET Intracranial Aneurysm Coiling Registry
NCT01748903
European eCLIPS™ Safety, Feasibility and Efficacy Study
NCT02607501
Tubridge Flow Diverter Study For Intracranial Aneurysms
NCT05646108
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Aneurysm clip
Patients presenting intracranial aneurysm (ruptured or unruptured) that the physician intends to treat with the Sugita clips.
Sugita Titanium Aneurysm Clip II
Aneurysm clipping is a surgical procedure used to treat brain aneurysms.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sugita Titanium Aneurysm Clip II
Aneurysm clipping is a surgical procedure used to treat brain aneurysms.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is adult, ≥18 years.
* As per national regulations, subject or subject's legally authorized representative (LAR) has signed written informed consent.
* Subject is willing to comply with scheduled visits and examinations per institutional standard of care.
Exclusion Criteria
* Subject has a condition which will not allow him/her to comply with his/her post-procedure follow up per the institutional standard of care (medical condition, subject living abroad and unable to return for follow- up, e.g.).
* Subject does not meet IFU criteria of the subject device.
* Subject is a child, \<18 years.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mizuho Corporation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitätsklinikum Essen
Essen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ulrich Sure, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CE-0005_CIP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.